NCT00003058View on ClinicalTrials.gov

Troglitazone in Treating Patients With Liposarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 30, 1997

Primary Completion Date

January 31, 2000

Study Completion Date

January 31, 2000

Conditions
Sarcoma
Interventions
DRUG

troglitazone

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00003058 - Troglitazone in Treating Patients With Liposarcoma | Biotech Hunter | Biotech Hunter